{
    "id": 17639,
    "fullName": "PPM1D L450*",
    "impact": "nonsense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PPM1D L450* results in a premature truncation of the Ppm1d protein at amino acid 450 of 605 (UniProt.org). L450* results in increase protein level of enzymatically active Ppm1d and growth advantage in cell culture (PMID: 23649806, PMID: 24880341).",
            "references": [
                {
                    "id": 4515,
                    "pubMedId": 24880341,
                    "title": "Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24880341"
                },
                {
                    "id": 4516,
                    "pubMedId": 23649806,
                    "title": "Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23649806"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8493,
        "geneSymbol": "PPM1D",
        "terms": [
            "PPM1D",
            "IDDGIP",
            "JDVS",
            "PP2C-DELTA",
            "WIP1"
        ]
    },
    "variant": "L450*",
    "createDate": "02/03/2016",
    "updateDate": "02/29/2016",
    "referenceTranscriptCoordinates": {
        "id": 98288,
        "transcript": "NM_003620",
        "gDna": "chr17:g.60663083T>A",
        "cDna": "c.1349T>A",
        "protein": "p.L450*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4397,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with the combination of SPI-001 and Adria (doxorubicin) resulted in decreased viability of colorectal cancer cells expressing PPM1D L450* in culture, compared to Adria (doxorubicin) alone (PMID: 25466181).",
            "molecularProfile": {
                "id": 17944,
                "profileName": "PPM1D L450*"
            },
            "therapy": {
                "id": 3501,
                "therapyName": "Doxorubicin + SPI-001",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4504,
                    "pubMedId": 25466181,
                    "title": "Inhibition of C-terminal truncated PPM1D enhances the effect of doxorubicin on cell viability in human colorectal carcinoma cell line.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25466181"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 17944,
            "profileName": "PPM1D L450*",
            "profileTreatmentApproaches": [
                {
                    "id": 7729,
                    "name": "PPM1D Inhibitor",
                    "profileName": "PPM1D L450*"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 98288,
            "transcript": "NM_003620",
            "gDna": "chr17:g.60663083T>A",
            "cDna": "c.1349T>A",
            "protein": "p.L450*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}